Mesoblast Ltd
F:LWBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
F:LWBA
|
AU |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
A
|
Advanced Micro Devices Inc
XHAM:AMD
|
US |
|
G
|
General Electric Co
SGO:GE
|
US |
|
A
|
argenx SE
F:1AE
|
NL |
|
C
|
CH Robinson Worldwide Inc
XMUN:CH1A
|
US |
|
R
|
Rajthanee Hospital PCL
SET:RJH
|
TH |
|
B
|
Baidu Inc
SGX:K3SD
|
CN |
|
Electronic Arts Inc
NASDAQ:EA
|
US |
|
Merck KGaA
F:MRKC
|
DE |
|
A
|
American Superconductor Corp
F:AMS1
|
US |
|
Fujitsu General Ltd
OTC:FGELF
|
JP |
|
D
|
Datang International Power Generation Co Ltd
XBER:BJI
|
CN |
|
F
|
Fluent Inc
SWB:7TM
|
US |
|
T
|
Toyota Industries Corp
OTC:TYIDF
|
JP |
|
FIRST BANK (Hamilton)
F:6UT
|
US |
|
F
|
Fluent Inc
F:7TM
|
US |
|
S&T Bancorp Inc
NASDAQ:STBA
|
US |
|
Allianz SE
XETRA:ALV
|
DE |
Bankruptcy Probability
Mesoblast Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mesoblast Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Mesoblast Ltd
ASX:MSB
|
2.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mesoblast Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mesoblast Ltd has total debt of 66m USD. This includes both short-term (0 USD) and long-term (66m USD) debt.
You can find a full breakdown on its Balance Sheet.
